EXOSOMEDX

Let us help you solve complex clinical and scientific challenges with liquid biopsy, exosome-based technology that is vastly superior to cfDNA and CTCs... The ExoDx Prostate test is now available to U.S. Veterans. The Veteran population has a two-fold increased risk of prostate cancer incidence compared to the general population but if detected early, prostate cancer is treatable. The ExoDx Prostate Test (EPI) provides actionable information that aids the prostate biopsy decision for men with PSA in the ‘gray zone' of 2-10 ng/mL and is not dependent on other clinical risk factors. Learn more about the EPI test including a testimonial of how the ExoDx Prostate test helped a 61-year old man facing a prostate biopsy... Simple urine test, non-DRE, included in the NCCN guidelines to help guide your patient to biopsy decision

Also known as: Exosome Diagnostics, Exosome Diagnostics GmbH, Exosome Diagnostics, Inc.

Primary location: Waltham United States